A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

September 30, 2005

Conditions
Alzheimer's Disease
Interventions
DRUG

SB-742457

Trial Locations (48)

1113

GSK Investigational Site, Sofia

1309

GSK Investigational Site, Auckland

1431

GSK Investigational Site, Sofia

1527

GSK Investigational Site, Sofia

2196

GSK Investigational Site, Rosebank

4000

GSK Investigational Site, Plovdiv

7130

GSK Investigational Site, Somerset West

7530

GSK Investigational Site, Oakdale

8002

GSK Investigational Site, Christchurch

9010

GSK Investigational Site, Varna

10000

GSK Investigational Site, Zagreb

21000

GSK Investigational Site, Split

28046

GSK Investigational Site, Madrid

57010

GSK Investigational Site, Thessaloniki

115522

GSK Investigational Site, Moscow

117049

GSK Investigational Site, Moscow

198103

GSK Investigational Site, Saint Petersburg

2352499

GSK Investigational Site, Valparaíso

7500710

GSK Investigational Site, Providencia / Santiago

A-6060

GSK Investigational Site, Hall in Tirol

A-6020

GSK Investigational Site, Innsbruck

A-2070

GSK Investigational Site, Retz

A-1040

GSK Investigational Site, Vienna

A-1130

GSK Investigational Site, Vienna

Unknown

GSK Investigational Site, Santiago

775 20

GSK Investigational Site, Olomouc

702 00

GSK Investigational Site, Ostrava

150 18

GSK Investigational Site, Prague

516 01

GSK Investigational Site, Rychnov nad Kněžnou

115 21

GSK Investigational Site, Athens

151 23

GSK Investigational Site, Athens

151 27

GSK Investigational Site, Melíssia

62-050

GSK Investigational Site, Mosina

10-082

GSK Investigational Site, Olsztyn

02-097

GSK Investigational Site, Warsaw

811 01

GSK Investigational Site, Bratislava

811 07

GSK Investigational Site, Bratislava

811 08

GSK Investigational Site, Bratislava

826 06

GSK Investigational Site, Bratislava

041 66

GSK Investigational Site, Košice

979 12

GSK Investigational Site, Rimavská Sobota

135-710

GSK Investigational Site, Seoul

150-719

GSK Investigational Site, Seoul

08003

GSK Investigational Site, Barcelona

08014

GSK Investigational Site, Barcelona

08025

GSK Investigational Site, Barcelona

08190

GSK Investigational Site, Sant Cugat Del Vallés/

08221

GSK Investigational Site, Tarrasa, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY